Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Share News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 530.00
Bid: 528.00
Ask: 534.00
Change: -6.00 (-1.12%)
Spread: 6.00 (1.136%)
Open: 540.00
High: 540.00
Low: 526.00
Prev. Close: 536.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday tips round-up: Unilever, Bloomsbury

Fri, 26th Oct 2012 08:03

Unilever yesterday announced that it is cutting costs. But it is not the only one, The Financial Times Lex column explains. Colgate Palmolive also said that it planned to cut 6 per cent of its workforce as part of an effort to save 40m dollars a year. Investors have warmed to Unilever of late, despite difficulties in its food business in Europe, where it got the price of its spreads wrong. The shares are up 11 per cent in the past year and have closed the traditional valuation discount with Procetr&Gamble. Both now trade on 18 times forecast earnings, which will be enough to put some shoppers off. But disappointments are growing in the consumer goods sector, and Unilever is one of the few companies to avoid them, so it is well worth putting some in the basket. Despite the challenging market backdrop, Unilever's strategy looks like it is working. Focusing on growth in emerging economies is boosting both the sales and profit - and the consumer products giant smashed expectations in the third quarter of the year. Shares in the Anglo-Dutch group hit an all-time high yesterday, following a particularly strong performance in Brazil. The company is no stranger to developing markets, having more than 50 years' experience in Brazil, China, India and Indonesia. For the group as a whole, Unilever said yesterday that it remained on track to deliver a modest improvement in operating margin, which last year came in at 14.9%. These numbers, in a challenging period, demonstrate that the group's emerging market strategy is on track. Questor has had a hold rating on the shares for some time because the valuation appears pretty full. Trading on a 2012 multiple of 18.2, falling to 16.7 next year and yielding 3.3 per cent, the view remains the same. However, Unilever really does look like it is now starting to deliver and The Telegraph´s Questor team has no compunction about advising investors to hold on.Bloomsbury Publishing saw its shares move lower yesterday after a mixed set of interim numbers. However, prospects for the second half of the year could be much better. The first half is traditionally weaker - with the key Christmas season being vital for book publishing. Releases lined up for the next few months include titles from celebrity chefs Hugh Fearnley-Whittingstall and Paul Hollywood, as well as a Hogwarts Library Boxed Set from J K Rowling and the latest novel from Will Self. Despite the fall in first-half profits the results were roughly in line with analysts' expectations. Sales and the dividend were higher than expected, although with profit being a touch light. However, there was evidence that the group's digital strategy is paying off. The company is focusing on electronic publishing, with its e-book sales rising by 89% in the period to £4.5m. Questor last recommended a buy at 117p in July, and the shares are now 11% ahead. They are trading on a current-year earnings multiple of 10.5 times, falling to 9.8 next year and yielding an attractive 4.3%, rising to 4.6%. Questor thinks this valuation looks full for now. Ahead of the key Christmas trading period, the rating is a hold.ABPlease note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.
More News
26 Mar 2018 21:56

Reuters Health News Summary

Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical Holding said its acute two a

Read more
26 Mar 2018 13:56

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Read more
26 Mar 2018 13:56

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Read more
26 Mar 2018 07:23

UPDATE 1-Roche's Tecentriq cocktail notches another lung cancer success

ZURICH, March 26 (Reuters) - Roche's immunotherapy Tecentriq combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss trial

Read more
25 Mar 2018 14:15

Israel to launch Big Data health project

By Maayan Lubell JERUSALEM, March 25 (Reuters) - Israel will invest nearly 1 billion shekels ($287 million) in a to a

Read more
20 Mar 2018 07:05

UPDATE 1-Roche says Tecentriq, chemo cut risk of death in type of lung cancer

ZURICH, March 20 (Reuters) - Roche's immunotherapy Tecentriq plus chemotherapy cut the risk of disease worsening or death in advanced squamous lung cancer, but it did not

Read more
19 Mar 2018 17:59

Bloomsbury Publishing Expecting Profitability To Beat Expectations

LONDON (Alliance News) - Bloomsbury Publishing PLC said on Monday it expects its full-year profit and revenue to both be ahead of expectations.For the year ending 28 to

Read more
20 Jan 2017 09:08

Bloomsbury Publishing Says Chairman Salz To Step Down In July

Read more
27 Oct 2016 07:43

Bloomsbury Publishing Sees Stronger Second Half As Trading In Line

Read more
13 Jul 2016 12:55

Bloomsbury Publishing plots expansion into B2B market

(ShareCast News) - Harry Potter publisher Bloomsbury Publishing held a capital markets day for investors and analysts on Wednesday to present plans to enter the business-to-business market, while also confirming first-quarter trading remained in line with full year expectations. Bloomsbury unveiled

Read more
13 Jul 2016 08:20

Bloomsbury Publishing Says Full Year Trading To Meet Expectations

Read more
12 Jul 2016 15:11

UK Shareholder Meetings Calendar - Next 7 Days

Read more
8 Jul 2016 15:00

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 May 2016 12:43

Bloomsbury moves towards digital B2B after strong FY

(ShareCast News) - Bloomsbury, the publisher behind the Harry Potter phenomenon, has turned in an overall strong set of full-year results and launched a 2020 strategy to move into digital B2B publishing. It booked a full-year pretax profit of £10.36m, from a year-earlier profit of £9.60m, with reven

Read more
19 May 2016 08:18

Bloomsbury To Reoganise Divisions As Profit Lifted By Children's Books

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.